MOH — authorised 13 November 2013
- Marketing authorisation holder: PHARMACYCLICS INC
- Status: likely_approved
MOH authorised Imbruvica on 13 November 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 13 November 2013.
PHARMACYCLICS INC holds the Israeli marketing authorisation.